论文信息 - Triple therapy with osimertinib, bevacizumab and cetuximab in EGFR-mutant lung cancer with HIF-1α/TGF-α expression - 字舞流文

Triple therapy with osimertinib, bevacizumab and cetuximab in EGFR-mutant lung cancer with HIF-1α/TGF-α expression

K. Kiura | M. Tabata | K. Hotta | Y. Maeda | K. Ohashi | Hisao Higo | Kazuya Nishii | E. Ichihara | Y. Kato | K. Ninomiya | T. Kubo | Kammei Rai | Go Makimoto | H. Watanabe | T. Nakasuka